Journal Article10.1016/0029-7844(96)00053-1
The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21
Anthony M. Vintzileos,Winston A. Campbell,Winston A. Campbell,Rodis Jf,Rodis Jf,Edwin R. Guzman,Edwin R. Guzman,John C. Smulian,John C. Smulian,Robert A. Knuppel,Robert A. Knuppel +10 more
118
TL;DR: Second-trimester genetic sonogram may be a reasonable alternative for patients at increased risk for fetal trisomy 21 who wish to avoid amniocentesis, and in experienced hands, this approach may result in a high detection rate of tr isomy 21, with an amniacentesis rate of less than 20%.
read more
About: This article is published in Obstetrics & Gynecology. The article was published on 01 Jun 1996. The article focuses on the topics: Trisomy & Amniocentesis.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists
TL;DR: Maternal mortality from postpartum obstetric hemorrhage has decreased since the late 1980s and accounted for slightly more than 10% of maternal mortalities in 2009 and is associated with increasing rates of transfusion and peripartum hysterectomy.
1.2K
Acog practice bulletin
Gynecologists
- 01 Jan 2009
TL;DR: Much of the review will, of necessity, focus on general principles of critical care, extrapolating where possible to obstetric critical care.
Screening for fetal aneuploidies at 11 to 13 weeks
TL;DR: Improvement in the performance of first‐trimester screening can be achieved by firstly, inclusion in the ultrasound examination assessment of the nasal bone and flow in the ductus venosus, hepatic artery and across the tricuspid valve, and secondly, carrying out the biochemical test at 9 to 10 weeks and the ultrasound scan at 12 weeks.
652
Meta‐analysis of second‐trimester markers for trisomy 21
Maria Agathokleous,Petia Chaveeva,Leona Poon,Przemek Kosinski,Kypros H. Nicolaides,Kypros H. Nicolaides +5 more
TL;DR: To summarize by meta‐analysis the accumulated data on the screening performance of second‐trimester sonographic markers for fetal trisomy 21 shows clear trends in maternal morbidity and mortality during the second trimester.
Practice Bulletin No. 175: Ultrasound in Pregnancy
01 Dec 2016
TL;DR: Obstetric ultrasonography is a common obstetric procedure used to provide information about fetal health and diagnose potential problems.
210
References
•Journal Article
Fetal pyelectasis: a possible association with Down syndrome.
TL;DR: Two hundred ten consecutive fetuses were identified as having renal pyelectasis among 7400 patients scanned during 1 year and seven of these 210 fetuses had Down syndrome.
197
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
James E. Haddow,Glenn E. Palomaki,George J. Knight,George C. Cunningham,Linda S. Lustig,Patricia A. Boyd +5 more
TL;DR: Prenatal screening of serum to generate individual estimates of the risk of Down's syndrome in the fetus can provide a basis for decision making in the cases of women 35 years of age or older, as it does in younger pregnant women, and is an alternative to current testing practices.
197
Sonographic scoring index for prenatal detection of chromosomal abnormalities.
TL;DR: The sonographically detectable physical features of second trimester fetuses are evaluated to determine whether these features are more sensitive and specific than maternal age for detecting fetuses with abnormal karyotypes and a weighted sonographic score was developed to optimize the detection of fetuses at risk for aneuploidy.
183
A sonographic screening method for Down syndrome
Charles J. Lockwood,Charles J. Lockwood,Beryl R. Benacerraf,Beryl R. Benacerraf,A. Krinsky,A. Krinsky,K. Blakemore,K. Blakemore,K. Belanger,K. Belanger,Maurice J. Mahoney,Maurice J. Mahoney,John C. Hobbins,John C. Hobbins +13 more
TL;DR: The biparietal diameter/femur length ratio may prove superior to current Down syndrome screening methods and, as a third independent variable, may significantly enhance the sensitivity and specificity of combined maternal age/maternal serum alpha-fetoprotein screening modalities.
177
Prenatal sonographic findings of Down syndrome: review of 94 cases.
TL;DR: Prenatal ultrasound findings were reviewed in 94 consecutive fetuses with proved Down syndrome (trisomy 21) during a 6-year period at a single institution and one or more abnormalities were found in 31 fetuses (33%) as mentioned in this paper.
169